NCT06696898 Effects of SSMC With and Without Myofascial Release in Patients With Sciatica
| NCT ID | NCT06696898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Sciatica Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2025-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2024-09-01 with a primary completion date of 2025-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sciatica involves a radiating pain along the sciatic nerve, extending from the lower back through the hips and buttocks to each leg. Typically resulting from a herniated disk or spinal stenosis, this condition causes nerve compression that leads to pain, inflammation, and often numbness in the affected leg. Studies have shown that sensorimotor training with myofascial release can be effective in improving pain, lumbar range of motion and functional disability. The aim of this study is to evaluate the effects of Sensorimotor control training with and without myofascial releases on Pain, Lumbar range of motion and functional disability due to sciatica. Participants which meet inclusion criteria will be randomly allocated using online randomization tool into two groups. Group A will receive somatosensory control training with Routine Physical Therapy for 45 minutes with short resting interval for Group B will receive Somatosensory training with myofascial release technique for 45min. Each group will receive treatment sessions of 3 days per week for 12 weeks.
Eligibility Criteria
Inclusion Criteria: * Patient Diagnosed with sciatica (confirmed by clinical examination and imaging) * Patient with Unilateral sciatica pain * Patient Experiencing symptoms for at least 3 months * Pain (VAS) score ≥ 5) in the lumbar and/or lower extremity region in patients. * The disability with a score of at least 20% by the Oswestry Disability Index ( * Stable patient , no recent changes in treatment regimen for sciatica within the past 4 weeks Exclusion Criteria: * Patients with Lumbar spine surgery history within the past 6 months (11) * Patients who have been Another clinical trial participant within the past 3 months (1). * Patients with Physical therapy interventions contraindicated like in Severe cardiovascular disease and Uncontrolled hypertension Acute disc herniation requiring urgent surgical intervention (10). * Patients with Significant comorbidities like malignancy, spinal infection and Severe osteoporosis affecting spine stability (14). * Inability in patients to communicate effectively in Urdu or English, hindering comprehension of study instructions and assessments.
Contact & Investigator
Aruba Saeed, Phd
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06696898 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 50 Years, studying Sciatica Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06696898 currently recruiting?
Yes, NCT06696898 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06696898 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06696898 clinical trial?
NCT06696898 is sponsored by Riphah International University. The principal investigator is Aruba Saeed, Phd at Riphah International University. The trial plans to enroll 74 participants.